132 related articles for article (PubMed ID: 6172643)
1. [Study of hemolysis in vitro for the purpose of detecting primaquine sensitivity].
Allakhverdiev AM; Grinberg LN
Lab Delo; 1981; (12):724-6. PubMed ID: 6172643
[No Abstract] [Full Text] [Related]
2. Effects of metabolites of primaquine and acetanilid on normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Fraser IM; Vesell ES
J Pharmacol Exp Ther; 1968 Jul; 162(1):155-65. PubMed ID: 5656594
[No Abstract] [Full Text] [Related]
3. Alterations in normal and G-6-PD deficient human erythrocytes of various ages after exposure to metabolites of hemolytic drugs.
Fraser IM; Tilton BE; Vesell ES
Pharmacology; 1971; 5(3):173-87. PubMed ID: 5119006
[No Abstract] [Full Text] [Related]
4. [Primaquine sensitivity of sheep erythrocytes].
Singh MK; Vincke E
Arzneimittelforschung; 1965 Aug; 15(8):917-9. PubMed ID: 5898648
[No Abstract] [Full Text] [Related]
5. The course of primaquine-induced haemolysis in G-6-PD-deficient Thais.
Charoenlarp P; Areekul S; Pholpothi T; Harinasuta T
J Med Assoc Thai; 1973 Jul; 56(7):392-7. PubMed ID: 4805904
[No Abstract] [Full Text] [Related]
6. [Clinical laboratory indices of hemolysis in persons with various types of haptoglobin in preventive primaquine therapy of malaria].
Shcherbakov AM; Ozeretskovskaia NN; Bronshteĭn AM; Benediktov II; Lachinova RI
Med Parazitol (Mosk); 1975; 44(3):288-92. PubMed ID: 1177820
[No Abstract] [Full Text] [Related]
7. Clinical manifestations of variant G-6-PD enzymes.
McCurdy PR
Ann Clin Lab Sci (1971); 1971; 1(2):184-92. PubMed ID: 4949448
[No Abstract] [Full Text] [Related]
8. The haemolytic effect of a single dose of 45 mg of primaquine in G-6-PD deficient Thais.
Charoenlarp P; Areekul S; Harinasuta T; Sirivorasarn P
J Med Assoc Thai; 1972 Nov; 55(11):631-8. PubMed ID: 4566625
[No Abstract] [Full Text] [Related]
9. [Influence of chloroquine and primaquine on red cell metabolism (author's transl)].
Waller HD; Lüer S; Benöhr HC
Klin Wochenschr; 1973 Dec; 51(24):1185-90. PubMed ID: 4789326
[No Abstract] [Full Text] [Related]
10. Nature of hemolytic crises and the fate of G6PD deficient, drug-damaged erythrocytes in Sardinians.
Salvidio E; Pannacciulli I; Tizianello A; Ajmar F
N Engl J Med; 1967 Jun; 276(24):1339-44. PubMed ID: 6024564
[No Abstract] [Full Text] [Related]
11. Studies of in vitro primaquine hemolysis: substrate requirement for erythrocyte membrane damage.
George JN; O'Brien RL; Pollack S; Crosby WH
J Clin Invest; 1966 Aug; 45(8):1280-9. PubMed ID: 5926074
[No Abstract] [Full Text] [Related]
12. Absence of hemolytic effects of L-DOPA on transfused G6PD-deficient erythrocytes.
Gaetani G; Salvidio E; Pannacciulli I; Ajmar F; Paravidino G
Experientia; 1970; 26(7):785-6. PubMed ID: 5431157
[No Abstract] [Full Text] [Related]
13. Oxidative activity of hydroxylated primaquine analogs. Non-toxicity to glucose-6-phosphate dehydrogenase-deficient human red blood cells in vitro.
Baird JK; Davidson DE; Decker-Jackson JE
Biochem Pharmacol; 1986 Apr; 35(7):1091-8. PubMed ID: 3754445
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced hemolysis: biochemical considerations.
Shahidi NT
Birth Defects Orig Artic Ser; 1970 Jun; 6(2):9-15. PubMed ID: 5522339
[No Abstract] [Full Text] [Related]
15. Effect of primaquine on erythrocytes with NADH-methaemoglobin reductase deficiency and low glutathione reductase activity.
Ajmar F; Gaetani G; Garré C; Bianchi G; Salvidio E
Br J Haematol; 1972 Sep; 23(3):333-41. PubMed ID: 5080351
[No Abstract] [Full Text] [Related]
16. Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
Ali NA; al-Naama LM; Khalid LO
East Mediterr Health J; 1999 May; 5(3):457-64. PubMed ID: 10793824
[TBL] [Abstract][Full Text] [Related]
17. G-6-PD deficiency and primaquine.
Vaidya AB; Rajagopalan TG; Baxi AJ
J Assoc Physicians India; 1983 Jan; 31(1):57. PubMed ID: 6619074
[No Abstract] [Full Text] [Related]
18. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology of diformyldapsone.
Cucinell SA; Rebert C; Clyde D
J Clin Pharmacol; 1974 Jan; 14(1):51-7. PubMed ID: 4491908
[No Abstract] [Full Text] [Related]
20. The hemolytic effect of primaquine V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity.
Dern RJ; Beutler E; Alving AS
J Lab Clin Med; 1981 Jun; 97(6):750-9. PubMed ID: 7229509
[No Abstract] [Full Text] [Related]
[Next] [New Search]
